Allarity Therapeutics, Inc. announced a private placement of a senior convertible promissory note at a principal amount of $660,000 issued at a discount of 10% for the gross proceeds of $600,000 on March 14, 2024. The note will have a coupon rate of 8% and will be convertible into common shares of the company at a conversion price of $0.3501 per share. The notes will be matured on March 14, 2025.